KARLEE KRISTENSEN: Open Payments
NPI 1417257635 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$550 in 34 payments from 11 companies in 2025. Trend: 2023 $496 · 2024 $584 · 2025 $550
Food & beverage: $550
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $288 |
| Astellas Pharma US Inc | 2 | $48 |
| E.R. Squibb & Sons, L.L.C. | 2 | $47 |
| PFIZER INC. | 3 | $45 |
| Dexcom, Inc. | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Radius Health, Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: VRAYLAR, QULIPTA, Veozah, NURTEC ODT, UBRELVY, Dexcom G6 Transmitter, ELIQUIS, CAMZYOS.
Industry payments across ND — which companies pay providers there.
